- Home
- STI vs MAIA Comparison
STI vs MAIA Comparison
Compare STI & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STI
- MAIA
- Stock Information
- Founded
- STI 2014
- MAIA 2018
- Country
- STI United States
- MAIA United States
- Employees
- STI N/A
- MAIA N/A
- Industry
- STI
- MAIA Biotechnology: Pharmaceutical Preparations
- Sector
- STI
- MAIA Health Care
- Exchange
- STI NYSE
- MAIA Nasdaq
- Market Cap
- STI 51.2M
- MAIA 44.8M
- IPO Year
- STI N/A
- MAIA 2022
- Fundamental
- Price
- STI $0.12
- MAIA $1.63
- Analyst Decision
- STI
- MAIA
- Analyst Count
- STI 0
- MAIA 0
- Target Price
- STI N/A
- MAIA N/A
- AVG Volume (30 Days)
- STI 35.6M
- MAIA 126.0K
- Earning Date
- STI 04-08-2025
- MAIA 03-21-2025
- Dividend Yield
- STI N/A
- MAIA N/A
- EPS Growth
- STI N/A
- MAIA N/A
- EPS
- STI N/A
- MAIA N/A
- Revenue
- STI $5,329.00
- MAIA N/A
- Revenue This Year
- STI N/A
- MAIA N/A
- Revenue Next Year
- STI N/A
- MAIA N/A
- P/E Ratio
- STI N/A
- MAIA N/A
- Revenue Growth
- STI 32.73
- MAIA N/A
- 52 Week Low
- STI $0.12
- MAIA $1.46
- 52 Week High
- STI $4.44
- MAIA $5.99
- Technical
- Relative Strength Index (RSI)
- STI 28.71
- MAIA 39.56
- Support Level
- STI $0.13
- MAIA $1.52
- Resistance Level
- STI $0.14
- MAIA $1.95
- Average True Range (ATR)
- STI 0.02
- MAIA 0.12
- MACD
- STI 0.01
- MAIA 0.01
- Stochastic Oscillator
- STI 2.68
- MAIA 24.51
About STI SOLIDION TECHNOLOGY INC
Solidion Technology Inc is engaged in researching, developing and manufacturing battery materials and components, as well as the development and production of next-generation batteries for energy storage systems and electric vehicles for ground, air, and sea transportation. It is recognized as a global IP leader in both the high-capacity anode and the high-energy solid-state battery.
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.